Lipopolysaccharide of Helicobacter pylori protects gastric mucosa via generation of nitric oxide

Journal of Physiology and Pharmacology

Volumn 48, Issue 4, 1997, Pages 699-717

  Brzozowski, T ^b   Konturek, P Ch ^b   Sliwowski Z ^b   Drozdowicz, D ^b   Pajdo, R ^b   Stachura, J ^b   Hahn, E G ^b   Konturek, S J ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b NONE

Author keywords

Gastric blood flow; Helicobacter pylori; INOS mRNA; Lipopolysaccharide gastroprotection; Nitric oxide; Nitric oxide synthase

Indexed keywords

DEXAMETHASONE; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; VIRULENCE FACTOR;

ANTIGEN ANTIBODY COMPLEX; CONFERENCE PAPER; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPEREMIA; HYPOTENSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH BLOOD FLOW; STOMACH LESION; STOMACH MUCOSA; STOMACH PROTECTION;

ANIMALS; BLOOD PRESSURE; ETHANOL; GASTRIC MUCOSA; HELICOBACTER PYLORI; LIPOPOLYSACCHARIDES; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PENICILLAMINE; RATS; RATS, WISTAR; RNA, MESSENGER; S-NITROSO-N-ACETYLPENICILLAMINE;

EID: 0031454080     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Lambert IR, Lin KS, Aranda-Michel I. Helicobacter pylori. Scand J Gastroenterology 1995; 30: (Suppl 208), 33-46.
2. Konturek PCh, Konturek SJ, Konturek JW. Gastric secretion and the pathogenesis of peptic ulcer in the Helicobacter pylori infection. J Physiol Pharmacol 1996; 47: 5-19.
3. Mégraud F, Neman SV, Brugmann D. Further evidence of toxic effect of ammonia produced by Helicobacter pylori in human epithelial cells. Infect Immun 1992; 60: 1859-1863.
4. Figura N, Crabtree IE. Helicobacter pylori vacuolating toxin, In Helicobacter Pylori: Basic Mechanism to Clinical Cure, RH Hunt, GNJ Tytgat (eds), Dodrecht, Kluwer Academic Publisher, 1994, p. 222.
5. Ernst PB, Reyes V, Jin Y, Navarro J, Crowe SE. Overview of the immune response to Helicobacter pylori. In Helicobacter Pylori: Basic Mechanism to Clinical Cure, Hunt RH, Tytgat GNJ (eds), Dordrecht, Kluwer Academic Publisher, 1994; p. 295.
6. Moran AP. The role of lipopolysaccharide in Helicobacter pylori pathogenesis. Aliment Pharmacol Ther 1996; 10: (Suppl 1), 39-50.
7. Piotrowski J, Yamaki K, Slomiany A, Slomiany BL. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide, effect of sucralfate. Am J Gastroenterol 1991; 86: 1756-1760.
8. Piotrowski J, Slomiany A, Slomiany BL. Inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide. Bioch Mol Biol Int 1993; 31: 1051-1058.
9. Mahatma M, Agrawal N, Dajani EZ, Nelson S, Nakamura C, Sitton J. Misoprostol but not antacid prevents endotoxin-induced gastric mucosal injury: role of tumor necrosis factor-alpha. Dig Dis Sci 1991; 36: 1562-1568.
10. Nagawa J, Hishinuma I, Hireta K. Involvement of tumor necrosis factor-alpha in the pathogenesis of activated macrophage-mediated hepatitis in mice. Gastroenterology 1990; 99: 758-765.
11. Slomiany BL, Murty VL, Piotrowski J, Slomiany A. Gastroprotective agents in mucosal defense against Helicobacter pylori. Gen Pharmacol 1994; 25: 833-841.
12. Piotrowski J, Majka J, Slomiany A, Slomiany BL. Helicobacter pylori lipopolysaccharide inhibition of gastric mucosal somatostatin receptor. Bioch Mol Biol Int 1995; 36: 491-499.
13. Young GO, Stemmet N, Lastovica A. Helicobacter pylori lipopolysaccharide stimulates gastric mucosal pepsinogen secretion. Aliment Pharmacol Ther 1992; 6: 169-177.
14. Tepperman BL, Brown JF, Whittle JR. Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol 1993; 265: G214-218.
15. 2+ -independent nitric oxide synthase activity in rat gastric mucosal cells. Eur J Pharmacol 1994; 292: 111-114.
16. Alican I, Kubes P. A critical role for nitric oxide in intestinal barrier function and disfunction. Am J Physiol 1996; 270: G225-237.
17. Tepperman BL, Soper BD. Nitric oxide synthase induction and cytoprotection of rat gastric mucosa from injury by ethanol. Can J Physiol Pharmacol 1994; 72: 1308-1312.
18. Tsuji K, Vehara A, Santos SB, Namiki M. Endotoxin protects the gastric mucosa against ulcerogenic stimuli. Biochem Biophys Res Comm 1993; 197: 1326-1333.
19. Lopez-Belmonte J, Whittle BJR, Moncada S. The actions of nitric oxide donors in the prevention induction of injury to the rat gastric mucosa. Br J Pharmacol 1993; 108: 73-78.
20. Parent IB. Membrane receptors on rat hepatocytes for the inner core region of bacterial lipopolysaccharide. J Biol Chem 1990; 265: 3455-3461.
21. Konturek SJ, Brzozowski T, Konturek P, Majka J, Dembinski A. Role of salivary glands and epidermal growth factor in gastric secretions and mucosal integrity in rats exposed to stress. Regul Pept 1991; 32: 203-215.
22. Brzozowski T, Konturek PCh, Konturek SJ, Ernst H, Stachura J, Hahn EG. Gastric adaptation to injury by repeated doses of aspirin strengthens mucosal defense against subsequent exposure to various strong irritants in rats. Gut 1995; 37: 749-757.
23. Brzozowski T, Konturek P, Sliwowski Z, Szlachcic A, Hahn EG, Konturek SJ. Adaptative cytoprotection by ammonia and urea-urease system in the rat gastric mucosa. J Physiol Pharmacol 1995; 46: 471-488.
24. Konturek SJ, Brzozowski T, Majka J, Szlachcic A, Pytko-Polonczyk J. Implications of nitric oxide in the action of cytoprotective drugs on gastric mucosa. J Clin Gastroenterol 1993; 17: (Suppl 1), 140-145.
25. Brzozowski T, Drozdowicz D, Szlachcic A, Pytko-Polonczyk J, Majka J, Konturek S.J. Role of nitric oxide and prostaglandins in gastroprotection induced by capsaicin and papaverine. Digestion 1993; 54: 24-28.
26. G-(1-Iminoethyl) lysine: A selective inhibitor of inducible nitric oxide synthase. J Med Chem 1994; 37: 3886-3888.
27. Salvemini D, Manning PT, Zweifel K et al. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J Clin Invest 1995; 96: 301-308.
28. Whittle BJR. Nitric oxide in gastrointestinal physiology and pathology. In Physiology of the Gastrointestinal Tract. Third edition, LR Johnson (ed), New York, Raven Press, 1994; p.267.
29. Green L, Tannenbaum SR, Goldman P. Nitrate synthesis in the germ-free and conventional rat. Science 1981; 212: 56-58.
30. Griffiths MJD, Liu S, Curzen NP, Messent M, Evans IW. In vivo treatment with endotoxin induces nitric oxide synthase in rat main pulmonary artery. Am J Physiol 1995; 268: L509-518.
31. Tanoue K, Ohta M, Tarnawski AS, Wahlstrom K, Sugimachi K, Sarfeh IJ. Portal hypertension activates the nitric oxide synthase genes in the esophageal mucosa of rats. Gastroenterology 1996; 110: 549-557.
32. Tsuji K, Uehara A, Okumura T et al. The gastric antisecretory action of lipopolysacharide is blocked by indomethacin. Eur J Pharmacol 1992; 210: 213-215.
33. Feng L, Xia Y, Garcia GE, Hwang D, Wilson CB. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α and lipopolysaccharide. J Clin Invest 1995; 95: 1669-1675.
34. Henderson B, Wilson M. Modulins: a new class of cytokine-inducing, pro-inflammatory bacterial virulence factor. Inflamm Res 1995; 44: 187-197.
35. Dignass AV, Podolsky DK, Rachmilewitz D. NO generation by cultured small intestinal epithelial cells. Dig Dis Sci 1995; 40: 1859-1865.
36. Ma TT, Ischiropoulos H, Brass CA. Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion. Gastroenterology 1995; 108: 463-469.
37. Bateson AN, Jakiwczyk OM, Schultz R. Rapid increase in inducible nitric oxide synthase gene expression in the heart during endotoxemia. Eur J Pharmacol 1996; 303: 141-144.
38. Uehara A, Okumura T, Tsuji K et al. Evidence that gastric antisecretory action of lipopolysacharide is not due to a toxic effect on gastric parietal cells. Dig Dis Sci 1992; 37: 1039-1044.
39. Satoh M, Matsumura T, Nakamoto M, Yamasaki M. Inhibition of TNF-triggering activity of lipopolysacharide by a proteinaceous factor from normal mouse liver extract. J Immunol 1995; 155: 877-885.
40. Hawkey CJ, Swannell AJ, Yeomans ND, Carlsson M, Floren I. Increased effectiveness of omeprazole compared to ranitidine in non-steroidal anti inflammatory drugs (NSAID) users with reference to H. pylori status. Gut 1996; 39: A149.
41. Eberhart CE, DuBois RN. Eicosanoids and the gastrointestinal tract. Gastroenterology 1995; 109: 285-301.